1. Current Perspective on the Natural Compounds and Drug Delivery Techniques in Glioblastoma Multiforme
    Tapan Behl et al, 2021, Cancers CrossRef

  2. Emerging Roles and Therapeutic Interventions of Aerobic Glycolysis in Glioma


    Wei Han et al, 2020, OncoTargets and Therapy CrossRef
  3. Metabolic reprogramming by the pyruvate dehydrogenase kinase–lactic acid axis: Linking metabolism and diverse neuropathophysiologies
    Mithilesh Kumar Jha et al, 2016, Neuroscience & Biobehavioral Reviews CrossRef
  4. Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma
    Philip Dao Trong et al, 2018, International Journal of Molecular Sciences CrossRef
  5. Associations between prediagnostic blood glucose levels, diabetes, and glioma
    Judith Schwartzbaum et al, 2017, Scientific Reports CrossRef
  6. Advances in the targeting of HIF-1α and future therapeutic strategies for glioblastoma multiforme
    Gang Wang et al, 2017, Oncology Reports CrossRef
  7. ANXA2P2/miR-9/LDHA axis regulates Warburg effect and affects glioblastoma proliferation and apoptosis
    Peng Du et al, 2020, Cellular Signalling CrossRef
  8. For glioma, a sweet side to diabetes
    Benjamin Purow, 2016, Neuro-Oncology CrossRef
  9. Mutant IDH1 confers resistance to energy stress in normal biliary cells through PFKP-induced aerobic glycolysis and AMPK activation
    Hiroaki Fujiwara et al, 2019, Scientific Reports CrossRef
  10. IDH-Mutant Gliomas
    Kensuke Tateishi et al, 2020, Brain and Spinal Tumors - Primary and Secondary CrossRef